milrinone has been researched along with Coronary Artery Stenosis in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "esmolol was infused to decrease baseline heart rate (HR) by approximately 25%, and all animals received an esmolol infusion (150 microg kg(-1) min(-1))." | 5.33 | Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs. ( Kirby, DS; Lobato, EB; Muehlschlegel, JD; Sidi, A, 2006) |
| "esmolol was infused to decrease baseline heart rate (HR) by approximately 25%, and all animals received an esmolol infusion (150 microg kg(-1) min(-1))." | 1.33 | Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs. ( Kirby, DS; Lobato, EB; Muehlschlegel, JD; Sidi, A, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sidi, A | 3 |
| Muehlschlegel, JD | 3 |
| Kirby, DS | 3 |
| Lobato, EB | 3 |
| Muehschlegel, JD | 1 |
3 other studies available for milrinone and Coronary Artery Stenosis
| Article | Year |
|---|---|
Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiac Output; Cardiotonic Agents; | 2006 |
Treating metabolic impairment and myocardial stunning with phosphodiesterase inhibitor type III, milrinone, administered prior to coronary artery occlusion in the presence of calcium channel blockade in pigs.
Topics: Analysis of Variance; Animals; Biomarkers; Blood Pressure; Calcium Channel Blockers; Cardiac Output; | 2007 |
Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary S | 2008 |